
Alicia Morgans
Director, Survivorship Program · Mass General Brigham
Credentials: · · · · · · ·
History
Research
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
The Lancet · 2020 · 1,345 citations
The Lancet Commission on prostate cancer: planning for the surge in cases
Review · The Lancet · 2024 · 592 citations
The Journal of Urology · 2022 · 411 citations
- NS
42 papers
- CR
28 papers

26 papers

22 papers

21 papers

18 papers · 8 as a resident

17 papers

17 papers · 1 as a fellow
Clinical trials
- 2026–2030
Principal investigator · Recruiting · Phase 2
Prostate Cancer Clinical Trials Consortium
- 2024–2028
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
Principal investigator · Recruiting · Phase 2
Dana-Farber Cancer Institute
- 2024–2027
CV CARE: CardioVascular Care in PC Patients
Principal investigator · Recruiting
Dana-Farber Cancer Institute
- 2021
Embr Thermal Device for Hot Flash Management in Prostate Cancer
Principal investigator · Completed
Embr Labs, Inc.


